KennethJWarringtonMD

Rheumatology • Rochester, MN

Vasculitis

John F. Finn MN Arthritis Foundation Professor of Medicine, Mayo Clinic College of Medicine and Science

Join to view full profile

Dr. Warrington is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Warrington's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Fax+1 507-284-0564

Summary

Dr. Kenneth Warrington is a rheumatologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from University of Malta School of Medicine and has been in practice 25 years. He specializes in vasculitis and is experienced in aortitis, takayasu's arteritis, giant cell arteritis, and polyarteritis nodosa. He has more than 100 publications and over 500 citings.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Rheumatology, 1999 - 2002
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1996 - 1999
University of Malta School of MedicineClass of 1992

Certifications & Licensure

MN State Medical License 2006 - 2025
TN State Medical License 2002 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

First Prize Abstract Award Mayo Clinic, 2012
Department of Medicine Laureate Award Mayo Clinic, 2011
Department of Medicine Career Development Time for Scholarly Physicians Award Mayo Clinic, 2009
Rheumatology Teacher of the Year Mayo Clinic, 2008
Junior Investigator Award Scleroderma Foundation, 2003
Philip Hench Award Mayo Clinic, 2002
Fellows Award American College of Rheumatology, 2001
Outstanding Medical Image Finalist in ACR Slide Competition American College of Rheumatology, 2001
Clinician Investigator Scholarship General Mills Foundation, 1999
Distinction in Orthopedics and General Surgery Malta Medical School, 1992
Distinction in Anatomy Malta Medical School, 1989
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

Baricitinib in Relapsing Giant Cell Arteritis Start of enrollment: 2017 Mar 09
Completed
Phase 2

Publications & Presentations

PubMed

Vasculitic Myopathy: Clinical Characteristics and Long-Term Outcomes.
Marcus V Pinto, Kenneth J Warrington, Pannathat Soontrapa, Matthew J Koster, Elie Naddaf
Neurology. 2024-12-24
Treatment trends of systemic lupus erythematosus from 2007 to 2023 in the USA.
Gabriel Figueroa-Parra, Herbert C Heien, Kenneth J Warrington, Nilay D Shah, Cynthia S Crowson
Lupus Science & Medicine. 2024-12-09
Plasma proteome profiling in giant cell arteritis.
Kevin Y Cunningham, Benjamin Hur, Vinod K Gupta, Matthew J Koster, Cornelia M Weyand
Annals of the Rheumatic Diseases. 2024-11-14

Journal Articles

Body mass index and the risk of giant cell arteritis-results from a prospective study
Jakobsson K, Jacobsson L, Warrington K , Matteson EL, Liang K, Melander O, Turesson C, Rheumatology, 9/1/2014
Cardiovascular risk and acute coronary syndrome in giant cell arteritis: A population based retrospective cohort study
Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ , Matteson EL, Arthritis Care Res, 7/1/2014
Vasculitis associated with rheumatoid arthritis: a case-control study
Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ, Rheumatology, 5/1/2014
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis
Kermani TA, Warrington KJ , Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL, Ann Rheum Dis, 12/1/2013
Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients
Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, Warrington KJ, Mayo Clin Proc, 8/1/2013
Comment on: How common is inflammatory marker-negative disease in giant cell arteritis?
Kermani TA, Warrington KJ, Eye, 5/1/2013
Biopsy findings in giant cell arteritis: relationship to baseline factors and corticosteroid treatment
Jakobsson K, Jacobsson L, Warrington K , Matteson EL, Turesson C, Scand J Rheumatol, 1/1/2013
Vasculitis Clinical Research Consortium Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis
Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P, Warrington KJ , Ytterberg SR, Hoffman GS..., Ann Rheum Dis, 8/1/2012
Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series
Kermani TA, Ytterberg SR, Warrington KJ, Arthritis Care Res, 5/1/2011
Malignancy risk in vasculitis
Kermani TA, Warrington KJ , Amin S, Ther Adv Musculoskelet Dis, 2/1/2011
Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study
Schafer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ, Rheumatology, 11/1/2010
Personalized medicine for the vasculitis patient: hope for the future?
Warrington KJ , Matteson EL, International Journal of Clinical Rheumatology, 4/1/2009
Treatment of giant cell arteritis
Warrington KJ, Clinical & Surgical Journal of Ophthalmology, 1/1/2008
Rheumatoid arthritis: emerging insights into the cause of rheumatoid arthritis
Warrington KJ , Weyand CM, Goronzy JJ, The Journal of Musculoskeletal Medicine, 10/1/2001
Join now to see all

Books/Book Chapters

Current therapy in vascular and endovascular surgery
Chapter: Giant cell arteritis
Kermani TA, Warrington KJEditors: Stanley JC; Veith FJ; Wakefield TW.Elsevier/Saunders, Philadelphia, PAEdition 5th,2014
Color Atlas and Synopsis of Vascular Medicine
Chapter: Granulomatosis with polyangiitis (Wegener)
Kermani TA, Warrington KJEditors: Dean SM; Satiani B; Abraham WT.McGraw-Hill Education/Medical, New York, NY2014
Color Atlas and Synopsis of Vascular Medicine
Chapter: Microscopic polyangiitis
Makol A, Warrington KJEditors: Dean SM; Satiani B; Abraham WT.McGraw-Hill Education/Medical, New York, NY2014
Color Atlas and Synopsis of Vascular Medicine
Chapter: Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis)
Makol A, Warrington KJEditors: Dean SM; Satiani B.McGraw-Hill Education/Medical, New York, NY2014
Challenging Cases in Rheumatology and Diseases of the Immune System
Chapter: Vasculitis: Giant Cell Arteritis
Kermani TA, Warrington KJEditors: M. Mahmoudi.Springer2013
Inflammatory diseases of blood vessels
Chapter: Vasculitis and relapsing polychondriti
Kermani TA, Warrington KJEditors: Hoffman GS; et al.Wiley-Blackwell2012
Systemic Vasculitis. Imaging Features
Chapter: Polyarteritis Nodosa
Friese JL, Warrington KJ, Miller DV, Ytterberg SR, Fleming CJ, Stanson AWEditors: Hendaoui L, Stanson AW, Bouhaouala MH, Joffre F.Springer2011
Rutherford's Vascular Surgery
Chapter: Vasculitis and Other Uncommon Arteriopathies
Warrington KJ , Cooper LTEditors: Cronenwett JL, Johnston W.ElsevierEdition 7th,2010
Monograph for British Medical Journal Point of Care
Chapter: Giant cell arteritis
Warrington KJ , Matteson EL2007
Mayo Clinic medical manual
Chapter: Connective tissue diseases
Warrington KJ , Ytterberg SREditors: Oliveira GHM, Nesbitt GC, Murphy JG.Mayo Clinic Scientific Press, Taylor & Francis Group, Boca Raton, FL2006
Join now to see all

Abstracts/Posters

Outcomes of Vascular Interventions in Takayasu's Arteritis: A Retrospective Cohort Study
Labarca CH, Makol A, Crowson CS, Kermani TA, Matteson EL, Warrington KJ, Ann Rheum Dis, 1/1/2014
Aortic dissection complicating Giant Cell Arteritis
Makol A, Kebed DT, Bois JP, Connolly HM, Foley TA, Askew JA, Maleszewski JJ, Greason KL, Schaff HV, Warrington KJ , Anavekar NS, Ann Rheum Dis, 1/1/2014
Aortic dissection and rupture in patients with giant cell arteritis a single center retrospective review of 195 consecutive patients
Kebed DT, Bois J, Connolly H, Bowen J, Warrington K , Foley T, Askew JW, Maleszewski J, Greason K, Schaff H, Anavekar N, Circulation, 11/1/2013
The stat1 signaling pathway in giant cell arteritis
Hartmann B, Liao J, Weisman MH, Warrington KJ , Goronzy JJ, Weyand CM, Arthritis Rheum, 10/1/2013
Infections requiring or acquired during hospitalizations in patients with giant cell arteritis - a population based retrospective cohort study
Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ , Matteson EL, Arthritis Rheum, 10/1/2013
Cardiovascular risk at incidence of giant cell arteritis: a population based retrospective cohort study
Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ , Matteson EL, Arthritis Rheum, 10/1/2013
Aortic dissection in giant cell arteritis: a population-based study of predictors
Kermani T, Warrington K, Crowson C, Hunder G, Ytterberg S, Gabriel S, Matteson E, Presse Med, 4/1/2013
Visual manifestations in giant cell arteritis: trend over five decades
Singh AG, Crowson CS, Kermani TA, Weyand CM, Matteson EL, Warrington KJ, Arthritis Rheum, 10/1/2012
Large vessel disease in giant cell arteritis: a population-based cohort study of incidence trends
Warrington KJ , Kermani TA, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL, Rheumatology, 2/1/2012
Computed Tomodensitometric (CT) Angiogarphic Imaging Characteristics of Idiopathic Aortitis: A Case Control Study
Chowdhary VR, Crowson CS, Warrington KJ , Vrtiska TJ, Ann Rheum Dis, 1/1/2012
Diagnosis of gout using dual-energy computed tomography: an accuracy and diagnostic yield study
Bongartz T, Glazebrook KN, Kavros SJ, Michet CJ, Merry SP, Murthy NS, Akkara Veetil BM, Davis JM III, Mason TG II, Warrington KJ , Manek NJ, Kermani TA, Hoganson DD, B..., Arthritis Rheum, 10/1/2011
Increased mortality in giant cell arteritis with large vessel disease: a population-based cohort study
Kermani TA, Warrington KJ , Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL, Arthritis Rheum, 10/1/2011
Serum biomarkers in GCA
Warrington KJ , Kermani TA, Crowson CS, Ytterberg SR, Matteson EL, Snyder MR, Clin Exp Immunol, 5/1/2011
Distribution of thoracic large arterial lesions in TA compared to GCA
Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, Monach PA, Seo P, Warrington KJ , Ytterberg SR, Merkel PA, Clin Exp Immunol, 5/1/2011
Lower Body Mass Index Is Associated with an Increased Risk of Giant Cell Arteritis
Jakobsson K, Jacobsson LT, Warrington KJ , Matteson EL, Liang KP, Melander O, Turesson C, Arthritis Rheumatism, 10/1/2010
Risk of malignancy in patients with Giant Cell Arteritis: A population-based study
Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ, Malta Medical Journal, 11/1/2009
Clinical predictors of biopsy proven giant cell arteritis
Karban MJ, Rieck KL, Abu Hilal MA, Thomsen KM, Harmsen WS, Warrington KJ, Journal of Oral and Maxillofacial Surgery, 9/1/2009
Lower extremity involvement in giant cell arteritis: a case series
Kermani T, Matteson EL, Hunder GG, Warrington KJ, Arthritis Rheum, 12/1/2008
Increased risk of peripheral arterial disease in polymyalgia rheumatica: A population-based cohort study
Jarpa E, Warrington KJ , Crowson CS, Cooper LT, Hunder GG, Matteson EL, Gabriel SE, Arthritis Rheum, 12/1/2007
Anti-fibrogenic T cells in scleroderma
Warrington KJ , Carbone LD, Nair U, Kang AH, Postlethwaite AE, Southern Society for Clinical Investigation Meeting, 2/1/2005
Type I collagen-specific memory CD4 T cells in scleroderma
Warrington KJ , Carbone LD, Nair U, Postlethwaite AE, Amgen Rheumatology Young Investigator Forum, 2/1/2004
Autoimmune lymphocyte response at sites remote to myocardial infarction
Gideon PA, Warrington KJ , Lu L, Sun Y, Weber KT, Circulation, 1/1/2003
Regulation of CD28 in senescent T cells
Vallejo AN, Bryl E, Warrington KJ , Weyand CM, Goronzy JJ, 2nd International Conference on Giant Cell Arteritis and Polymyalgia Rheumatica, Meeting on GCA-PMR, 8/1/2002
Ontogenesis of CD28null T cells in the aging immune system
Vallejo AN, Bryl E, Warrington KJ , Lewis DE, Merced-Sauvage M, Weyand CM, Goronzy JJ, Conference on Immunology & Aging, 4/1/2002
IL-12 mediated activation of cytotoxic CD4 T cells in acute coronary syndromes
Nakajima T, Abbas AE, Schultz S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM, J Am Coll Cardiol, 3/1/2002
Join now to see all

Lectures

Current advances in the diagnostic imaging for vasculitis. CAT scan, MRI, PET? Which to choose?
Santa Monica, CA - 10/1/2014
My doctor says my vasculitis is in “remission”; so why do I still feel unwell? The current state of damage and disease activity assessment in vasculitis. Strategies to...
Santa Monica, CA - 10/1/2014
Polymyalgia Rheumatica and Giant Cell Arteritis
Norwalk, CT - 1/1/2014
Giant Cell Arteritis
Fargo, ND - 10/1/2013
Vasculitis Concurrent Abstract Session
San Diego, CA - 10/1/2013
Giant Cell Arteritis - Large Vessel Vasculitis
San Diego, CA - 10/1/2013
Conventional Immunosuppressive Agents in the Treatment of Giant Cell Arteritis and Takayasu Arteritis
Cleveland, OH - 5/1/2013
Large vessel disease in Giant Cell Arteritis: A population-based cohort study of incidence trends
Madrid, Spain - 1/1/2012
Refractory Rheumatoid Pericarditis
Chicago, IL - 11/1/2011
Pathogenesis of Large Vessel Vasculitis
Santiago, Chile - 4/1/2011
Polymyalgia Rheumatica and Giant Cell Arteritis: Update on diagnosis and Treatment
Santiago, Chile - 4/1/2011
Takayasu Arteritis: Update on diagnosis and treatment
Santiago, Chile - 4/1/2011
Extracranial Giant Cell Arteritis
Santiago, Chile - 4/1/2011
Pneumocystis Jirovecii Pneumonia in patients with Giant Cell Arteritis: A review of clinical features and outcomes
Rome, Italy - 6/1/2010
What's New in Vasculitis
St. Paul, MN - 11/1/2009
Risk of Malignancy in patients with Giant Cell Arteritis: A population-based study
Malta - 11/1/2009
Update on Giant Cell Arteritis
Santiago, Chile - 5/1/2008
Aortitis
Washington, DC - 8/1/2007
Challenging GCA cases
Washington, DC - 8/1/2007
Giant Cell Arteritis – The Mayo Clinic Experience
Freiburg, Germany - 6/1/2007
The Coxib Controversy – To Use or Not To Use
Memphis, TN - 3/1/2006
Lymphocyte activation and upregulation of anti-fibrotic cytokines by pamidronate treatment of patients with limited or diffuse scleroderma
San Diego, CA - 11/1/2005
Characterization of the Immune Response to Collagen in Scleroderma
Atlanta, GA - 10/1/2004
Rheumatoid Arthritis is an idependant risk factor for accelerated coronary artery disease
San Francisco, CA - 11/1/2001
Join now to see all

Authored Content

Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)November 2022
Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Join now to see all

Press Mentions

Innovative Blood Analysis Technique Reveals Insights into Giant Cell ArteritisNovember 20th, 2024
FDA Gives Thumbs up to ANCA-Associated Vasculitis DrugOctober 8th, 2021
Avacopan for ANCA Vasculitis: A New Treatment Paradigm?February 17th, 2021
Join now to see all